Home / People / Agnieszka Starzyńska
Portrait of Agnieszka Starzyńska

Agnieszka Starzyńska

Head of Life Sciences and Healthcare, Poland

CMS Cameron McKenna Nabarro Olswang Pośniak i Bejm sp.k.
Warsaw Financial Centre
ul. Emilii Plater 53
00-113 Warsaw
Languages English, Polish

Agnieszka Starzyńska is Counsel in CMS Warsaw’s Competition and Public Procurement Team.

Her competition law experience includes advising clients on issues related to anti-competitive agreements and practices, abuse of dominant position and acts of unfair competition. She has often represented clients in proceedings before the Polish Competition Authority.

Agnieszka has participated in multiple merger control notifications, including creating joint ventures as well as share and asset acquisitions.

A significant part of her experience includes advising contracting authorities and contractors on numerous public procurement projects, both on conducting the tender procedure and the preparation and effective submission of bids. Agnieszka has experience in drafting legal remedies and representing clients before the National Appeal Chamber (KIO).

more less

Relevant experience

  • A leading global manufacturer of baby food on various competition matters relating to the sale of products through both modern and traditional channels (including pricing issues, rebates, shelf space arrangements, shop exclusivity, category management, etc.).
  • A UK-based sporting goods retailer on various regulatory and commercial issues connected with opening its stores in Poland.
  • A multinational consumer products corporation on all aspects of the Polish subsidiary’s day-to-day operations, including reviewing commercial contracts and advising on promotional sales strategy.
  • One of the biggest food and drinks producers in CEE on merger control aspects of the acquisition of a Polish producer of food supplements, including preparing a merger control notification to the Polish Competition Authority and representing the client in merger control proceedings before the Authority.
  • One of the biggest developers of industrial and warehouse premises in Poland on creating a joint venture in Poland with its business partner. The advice required high-level expertise on the local markets for the rental of warehouse premises as well as relating to the real estate sector. The advice included preparing a merger control notification to the Polish Competition Authority and representing the client in merger control proceedings before the Authority.
  • An international construction company on a public procurement procedure for building, reconstructing and maintaining certain regional roads in central Poland. Providing legal assistance on preparing a complete application for participation in a competitive dialogue.
  • An international firm specialising in consulting, engineering and project management in the construction field before the National Appeal Chamber in the tender for the design of a flood protection system for a city in northern Poland.
more less

Memberships & Roles

  • Advocate -  Warsaw Bar of Advocates
  • Member - Competition Law Association in Poland
  • Member - Public Procurement Association in Poland
more less


  • 2010 – Master’s Degree, Faculty of Law and Administration, University of Warsaw, Warsaw
  • 2010 – Diploma Course in English and EU law, Cambridge University and Warsaw University, Warsaw
  • 2021 – Post-graduate degree in Management in Life Sciences Sector, Lazarski University, Warsaw
more less
Life Sciences & Healthcare

Agnieszka Starzynska is an advocate and heads the Life Sciences and Healthcare Practice in Poland. 

She specialises in life sciences, as well as commercial, competition, and consumer protection matters. A major part of her experience consists in advising entities that operate in the pharmaceutical and medical device sectors on issues related to clinical trials, developing and placing products on the market, marketing and advertising, relations with HCPs and HCOs, and products. Agnieszka takes part in internal audits and advises on compliance matters.

She also advises companies on regulatory, compliance and liability issues in relation to cannabis, cosmetics or food supplements offered for sale. 

Agnieszka provides assistance to major clients from the life sciences sector in their day-to-day business activities, including various supply, distribution and service agreements, contracts with CROs, clinical sites and investigators, and consumer communication and promotions. 

more less

Relevant experience

  • A multinational medical company on matters related to regulatory and competition laws, including an analysis of clinical trial contracts and medical device sales contracts;
  • A soft contact lens manufacturer on various regulatory and compliance matters, including advice on consumer terms, conditions and transparency of various promotional schemes for medical devices (including reimbursed medical devices);
  • A global pharmaceutical group that offers healthcare solutions in over 170 countries on the transfer to another entity of marketing authorisations for medicinal products;
  • A leading CRO on introducing a new model of cooperation with their employees, including a review of whether it could affect the role of CRO in clinical trials.
more less

Memberships & Roles

  • Advocate – Warsaw Bar of Advocates
  • Member – Competition Law Association in Poland
  • Member – Public Procurement Association in Poland
more less


  • 2010 – Master's Degree, Faculty of Law and Administration, University of Warsaw, Warsaw
  • 2010 – Diploma Course in English and EU law, Cambridge University and Warsaw University, Warsaw
  • 2021 – Post-graduate degree in Management in Life Sciences Sector, Lazarski University, Warsaw
more less
10 key as­pects of the re­vised EU com­pet­i­tion law in the field of dis­tri­bu­tion...
The new Ver­tic­al Block Ex­emp­tion Reg­u­la­tion (VBER) and the new ac­com­pa­ny­ing Ver­tic­al Guidelines (VGL) were pub­lished on 10 May 2022. The new VBER will enter in­to force on 1 June 2022 and ap­ply for the next twelve years. The new VBER/VGL in­tro­duce sev


No more hid­den ad­vert­ising of products by in­flu­en­cers? Re­com­mend­a­tions...
As part of an in­vest­ig­a­tion in­to re­ports that Pol­ish con­sumers were be­ing misled over so­cial me­dia, Po­lan­d's Of­fice of Com­pet­i­tion and Con­sumer Pro­tec­tion (UOKiK) is­sued Re­com­mend­a­tions per­tain­ing to...
CMS ad­vises Brod­vik AB on the sale of SITS
In­ter­na­tion­al law firm CMS has ad­vised Brod­vik AB on the sale of 100% of shares in SITS sp z o.o. to Ac­tona Group A/S. Brod­vik AB is a Swedish whole­saler of fur­niture, car­pets and light­ing equip­ment...
Pol­ish bill to reg­u­late fran­chising now be­ing draf­ted
In Po­land, the ne­ces­sity of reg­u­lat­ing fran­chising has been widely dis­cussed in re­cent years, res­ult­ing in the an­nounce­ment that a bill on this is­sue is now be­ing draf­ted, along with re­ports and dis­cus­sions...
Phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising in...
1. Which laws are ap­plic­able re­gard­ing ad­vert­ising of medi­cines and med­ic­al devices? The main act provid­ing the leg­al frame­work for ad­vert­ising of medi­cin­al products is the Phar­ma­ceut­ic­al Law of 6 Septem­ber...
Ad­vert­ising food sup­ple­ments - are we in for a re­volu­tion?
The top­ic of food sup­ple­ments is re­turn­ing yet again – this time the gov­ern­ment is plan­ning changes con­cern­ing the present­a­tion and ad­vert­ising of food sup­ple­ments. On 2 Septem­ber 2022, in­form­a­tion...
Can­nabis law and le­gis­la­tion in Po­land
Med­ic­al use Pol­ish le­gis­la­tion does not gen­er­ally al­low the grow­ing of can­nabis that con­tains more than 0.3% THC in flower­ing or fruit­ing tops of plants from which the res­in has not been re­moved (Non-Fibrous...
Pub­lic pro­cure­ment reg­u­la­tion in Po­land
Decem­ber 2018 1. Where can one find pub­lic pro­cure­ment no­ti­fic­a­tions for Po­land? In­form­a­tion about pub­lic tenders in Po­land may be found in the on­line ver­sion of the Sup­ple­ment to the Of­fi­cial Journ­al...
New reg­u­la­tions on ad­vert­ising med­ic­al devices – what can we ex­pect?
On 28 Ju­ly 2022, a draft Reg­u­la­tion of the Min­is­ter of Health on the ad­vert­ising of med­ic­al devices (the “Draft Reg­u­la­tion”) was pub­lished. The Draft is in­ten­ded to be a cla­ri­fic­a­tion of the tech­nic­al...
The Pol­ish Com­pet­i­tion Au­thor­ity to con­trol for­eign in­vest­ments un­til 24...
On May 2022, the Pres­id­ent of the Re­pub­lic of Po­land signed an amend­ing act, pur­su­ant to which the pro­vi­sions of the Act of 24 Ju­ly 2015 on the con­trol of cer­tain in­vest­ments (“Act”)[1], grant­ing...
Ad­verse ef­fects of drugs and vac­cines in Po­land
1. Drug ad­verse ef­fects: kinds of re­spons­ib­il­ity 1.1 Which are the main kinds of re­spons­ib­il­ity (con­trac­tu­al, in tort, crim­in­al) of the fol­low­ing sub­jects with re­spect to ad­verse drugs re­ac­tions? 1. Man­u­fac­tur­ers­Man­u­fac­tur­ers...
Re­tail­er­'s Guide to Po­land 2022
We are de­lighted to present the 2022 edi­tion of CMS Re­tail­er’s Guide to Po­land.The re­tail busi­ness has its own spe­cif­ics that re­quire tail­or-made leg­al solu­tions. This guide provides an ana­lys­is of...
Un­fair trad­ing prac­tices in the ag­ri­cul­tur­al and food sup­ply chain in Po­land
1. How are un­fair trad­ing prac­tices in the ag­ri­cul­tur­al and food chain reg­u­lated in this jur­is­dic­tion? When the ap­plic­able reg­u­la­tions were in­tro­duced and when they were last amended? In Po­land, un­fair...